Ambenet GmbH Das Ambulante Behandlungsnetz
Verified
Leipzig, Germany
Rare diseases
Investigational molecules
Locations
A plain-language summary of the goals, design and what participants do
This study is being done in people with obesity or overweight who also have other health problems linked to body weight and who do not have diabetes. The treatment being studied is KAI-9531, given as a subcutaneous injection under the skin once a week. Some people in the study will receive a placebo.
The purpose of the study is to see how well KAI-9531 works and how safe it is. Participants are assigned by chance to receive either KAI-9531 or placebo, and neither the participants nor the study team know which treatment is being given during the study. The study continues for a long period while regular injections are given and health is followed over time.
During the study, body weight and other health measures are checked at planned visits. The study looks at changes in weight, waist size, blood pressure, blood fats such as triglycerides and cholesterol, blood sugar, and quality of life related to physical function. Safety is also monitored through medical checks, blood tests, heart tracing with ECG, and review of any side effects.
2 criteria
10 criteria
Tell us about your condition – we search every trial in Europe and connect you with the right site.
We usually reply within a few days
All sites with verified contact details – recruitment status may not be available; ask directly
Leipzig, Germany
Budapest, Hungary
Plovdiv, Bulgaria
Where you can join this trial
Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.
Not recruitingJoining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.
is the study medicine being tested in this trial. It is given as a subcutaneous injection, which means it is injected under the skin once a week. The goal of the study is to see whether it helps people with obesity or overweight and related health problems lose weight safely and effectively.
is a look-alike injection that does not contain any active medicine. It is used for comparison so the researchers can better tell whether KAI-9531 is working. It is given in the same way as the study medicine so neither the participants nor the study team knows who is receiving the real treatment or the placebo during the trial.
sourced from the EU Clinical Trials Register and site verification
Want to learn more about this trial or check if you can participate?
Tell us about your condition – we search every trial in Europe and connect you with the right site.